Writer of the article:
Revealed Feb 03, 2025 • 3 minute learn
Article content material
Advert hoc announcement pursuant to artwork. 53 SIX Swiss Trade Itemizing Guidelines
Article content material
Article content material
- President Area Worldwide, Francisco Ballester, to retire as of March 1, 2025, after 34 years of service
- Peter Stenico, presently World Platform Head Biosimilars and Nation President Sandoz Austria, concurrently appointed President Area Worldwide and a member of the Sandoz Government Committee
Basel, February 3, 2025 – Sandoz, the worldwide chief in generic and biosimilar medicines, introduced immediately that Francisco Ballester, President Area Worldwide and member of the Sandoz Government Committee, will retire and step down from the SEC on March 1, 2025. Since 2019, Francisco has been accountable on this position for driving enterprise development and entry for sufferers in markets exterior of North America and Europe, whereas creating extremely numerous abilities within the area. He’s a member of the Well being Administration and Coverage Advisory Council of the Miami Herbert Enterprise Faculty.
Commercial 2
Article content material
Drawing on a powerful bench of inner leaders, Peter Stenico will succeed Francisco. Peter was appointed World Platform Head, Biosimilars in January 2023 and has led the Sandoz world biosimilar technique. Beforehand, Peter held the place of Nation Head and Basic Supervisor for Sandoz in Germany and was additionally the previous President of the German Generics Affiliation (Professional Generika). Peter joined Sandoz in 2002 and has gained huge biosimilars and generics business expertise by varied roles masking technique, M&A and business at world, regional and native ranges.
Richard Saynor, Chief Government Officer of Sandoz, mentioned: “It isn’t day by day we will acknowledge a colleague who has devoted just about his complete profession to our firm. Francisco spent over three a long time taking over numerous and more and more extra senior roles on the group, demonstrating focus, ardour, and dedication to the enterprise and our individuals. I’m personally grateful for his many contributions and insights we now have labored collectively on the Sandoz Government Committee. I want Francisco all the easiest for his retirement.
High Tales
Article content material
Commercial 3
Article content material
I’m immensely pleased with the massive wealth of expertise we now have at Sandoz. Like Francisco, Peter can look again on a profitable profession of many a long time at Sandoz and he’ll deliver this in depth expertise to his new position and to the Sandoz Government Committee. I welcome him to the crew and want him a lot success in taking Sandoz Area Worldwide to the following stage of development.”
DISCLAIMER
This Media Launch incorporates forward-looking statements, which supply no assure with regard to future efficiency. These statements are made on the idea of administration’s views and assumptions concerning future occasions and enterprise efficiency on the time the statements are made. They’re topic to dangers and uncertainties together with, however not confined to, future world financial situations, alternate charges, authorized provisions, market situations, actions by opponents and different components exterior of the management of Sandoz. Ought to a number of of those dangers or uncertainties materialize or ought to underlying assumptions show incorrect, precise outcomes could differ materially from these forecasted or anticipated. Every forward-looking assertion speaks solely as of the date of the actual assertion, and Sandoz undertakes no obligation to publicly replace or revise any forward-looking statements, besides as required by regulation.
Commercial 4
Article content material
ABOUT SANDOZ
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the worldwide chief in generic and biosimilar medicines, with a development technique pushed by its Goal: pioneering entry for sufferers. Greater than 20,000 individuals of 100 nationalities work collectively to make sure 800 million affected person therapies are offered by Sandoz, producing substantial world healthcare financial savings and a fair bigger social affect. Its main portfolio of roughly 1,500 merchandise addresses illnesses from the widespread chilly to most cancers. Headquartered in Basel, Switzerland, Sandoz traces its heritage again to 1886. Its historical past of breakthroughs consists of Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2023, Sandoz recorded internet gross sales of USD 9.6 billion.
CONTACTS
Attachment
Article content material
